Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $133.00. The company’s shares ...

Abbott Laboratories' (NYSE:ABT) stock up by 8.7% over the past three months. Since the market usually pay for a... We recently compiled a list of the Jim Cramer’s Top 10 Stock Picks You Can’t ...

Texas Governor Greg Abbott announced that the state is taking an aggressive stand against the violent Venezuelan gang, Tren de Aragua (TdA) and declaring the group a "foreign terrorist organization." ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Diane Abbott has reignited her row with Sir Keir Starmer over anti-Semitism by suggesting “allies” of the Prime Minister are treated differently from his enemies when such accusations are made.

The ABBOTT PRISM System is an automated immunoassay ... technology is now being used in most major hospitals and reference laboratories and is now available in the transfusion market.

Edward Jones has recently reduced Abbott Laboratories (ABT) stock to Hold rating, as announced on July 30, 2024, according to Finviz. Earlier, on May 30, 2024, Goldman had initiated the stock to Buy, ...